The RAS Initiative enlists collaborators from all sectors of the research community to work together to attack mutant RAS-driven cancers. Provocative Questions is an NCI initiative that intends to assemble a list of important questions, or problems that are paradoxes in cancer research that will stimulate research communities to use laboratory, clinical, and population sciences in new, effective, and imaginative ways. The Outstanding Investigator Award gives investigators the freedom to work on long-term projects with unusual potential in cancer research. NCI is accepting applications for research grants that support the Cancer Moonshot Blue Ribbon Panel recommendations to speed progress in cancer research and lead to improved cancer prevention, detection, and treatment.Įarly Stage Investigators who have submitted an R01 application within the NCI payline may be eligible for consideration for the Method to Extend Research in Time (MERIT) (R37) Award. New funding notices will be added to this page as they become available. NCI is providing funding for research on COVID-19 and revising certain existing grants and cooperative agreements to make funds available to help address the public health crisis. NCI Special Initiativesįunding Announcements and Notices for COVID-19 Find current and recent NCI-supported RFAs that provide funding for various areas of cancer research.įind current and recent PAs that invite requests for funding applications to support specific area of cancer research.įind current and recent NCI and Trans-NIH Research Project Grants (R01 and R21) that provide funding for specific areas of cancer research.įind opportunities for contract funding.
0 kommentar(er)
